Regeneron to Present at Lehman Brothers 10th Annual Global Healthcare Conference
Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, will provide an overview of the Company and its clinical programs. The presentation is scheduled to be broadcast live on Monday, March 19 at 11:15 a.m. Eastern Time. The session may be accessed through the Company's website (www.regeneron.com on the Events page, under the Investor Relations heading) at the time of the presentation. An archived version of the presentation will be available after the live webcast through April 18, 2007.
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.
Additional information about Regeneron and recent news releases are available on Regeneron's worldwide web site at www.regeneron.com
CONTACT: Regeneron Pharmaceuticals, Inc.
Charles Poole
Vice President, Investor Relations
914-345-7640
charles.poole@regeneron.com
or
Media Relations
Lauren Tortorete, 212-845-5609
ltortorete@biosector2.com
SOURCE: Regeneron Pharmaceuticals, Inc.